Developer docs
API playgroundTry for free, no card

Search company profiles

Multi Channel Systems

Full company profile

uuid000ir9k

Namestring
Multi Channel Systems
Legal namestring
Multi Channel Systems MCS GmbH
Company typeenum
Private
Founded yearint
1996
Descriptiontext

Multi Channel Systems MCS GmbH (MCS) is a German manufacturer of microelectrode array (MEA) electrophysiology systems, founded in 1996 and headquartered in Reutlingen, Baden-Württemberg. The company operates as a wholly-owned subsidiary of Harvard Bioscience, Inc. (NASDAQ: HBIO) and is grouped, with HEKA Elektronik and Warner Instruments, into Harvard Bioscience's Smart Ephys division serving pre-clinical research markets. MCS sells to academic neuroscience researchers, pharmaceutical and biotech drug discovery and safety pharmacology groups, and diabetes research institutions globally, with direct sales and e-commerce coverage in Europe, Australia, and New Zealand and third-party distributors elsewhere.

MCS's portfolio spans in vitro and in vivo electrophysiology. The core platform is the MEA2100 system family (60–256 electrodes, 24-bit A/D, integrated stimulation, temperature control, perfusion, DC–10 kHz bandwidth). Above it sits the CMOS-MEA5000 (4,225 recording electrodes and 1,024 stimulation sites on a 65×65 grid at 16–32 µm pitch, 25 kHz sampling) for sub-cellular resolution, and the Multiwell-MEA (24/96-well format, up to 1,152 electrodes, 50 kHz) for high-throughput screening. Specialized offerings include the Beta-Screen system for intact islet recordings in diabetes research, the Incub8 Multiwell MEA for combined optical and electrophysiological recording inside a CO2 incubator, the wireless W2100 and tethered ME2100 for in vivo work, and — since 2024 — the AcadeMEA entry-level system and MEA Xpress automated liquid-handling platform. The 2025 Mesh MEA (a 7 µm polyimide 60-electrode mesh enabling inside-organoid recordings) and the 2024 Foresee Biosystems IntraCell partnership (laser-based optoporation for intracellular action potentials) extend the portfolio into 3D and intracellular assays. Software (Multi Channel Suite, Multiwell-Screen, CMOS-MEA-Control, Beta-Screen Experimenter and Analyzer) and a universal interface board (IFB-C, programmable DSP, USB 3.0) complete the workflow. Disposable MEAs in standard, CMOS, FlexMEA, and EcoFlexMEA variants, plus stimulus generators, perfusion, and micromanipulator accessories, supply the consumables and peripherals.

Revenue is generated through hardware system sales, recurring software licenses and 2-year service/maintenance plans, and disposable MEA consumables. Pricing is quote-based and gated to registered B2B accounts. The go-to-market combines a direct European/Australian field-sales motion (with 'Request a Demo' and 'Schedule a Meeting' CTAs), a B2B online shop, conference and webinar participation, and a worldwide distributor network outside direct territories. With 51–100 employees and a single R&D-and-manufacturing footprint, MCS runs a specialized, high-touch scientific-tools model where the installed base of instruments and consumable arrays drives recurring revenue.

Short descriptiontext

Multi Channel Systems MCS GmbH manufactures microelectrode array (MEA) electrophysiology systems, consumable electrode arrays, and software for neuroscience, pharmaceutical drug discovery, cardiotoxicity, and diabetes research. It is a wholly-owned subsidiary of Harvard Bioscience Inc. (NASDAQ: HBIO), headquartered in Reutlingen, Germany.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersReutlingen, Germany
HQ citystring
Reutlingen
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
microelectrode array systems, electrophysiology equipment, neuroscience research instruments, cardiotoxicity screening tools, in vivo recording systems
Industry3 codes
PRIMARYHDAHALAK
Biosensors & Lab-on-Chip (BioMEMS)
SECONDARYHDAHALAO
Sensor Fusion, Interface ICs & Modules (AFE/Readout/Packaging/Calibration)
SECONDARYHDAHAAAG
Sensors, MEMS & Imaging ICs
NAICS code3 codes
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
  • Analytical Laboratory Instrument Manufacturing334516
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Laboratory Analytical Instruments3826
  • Instruments For Meas & Testing Of Electricity & Elec Signals3825
Product category
Electrophysiology Equipment
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model5 records
1MEA Systems Hardware
TypeHardware Sales
Description

Complete microelectrode array systems including amplifiers, headstages, interface boards, and data acquisition units for in vitro and in vivo electrophysiology research.

multichannelsystems.com
2Microelectrode Arrays
TypeHardware Sales
Description

Disposable MEA chips including standard, CMOS, FlexMEA, and specialized arrays. Electrodes include titanium nitride, gold, and PEDOT coatings with various layouts (24-4225 electrodes).

multichannelsystems.com
3Software Licenses and Updates
TypeSubscription Recurring
Description

Data acquisition and analysis software including Multi Channel Suite, Multiwell-Screen, CMOS-MEA-Control, Beta-Screen Experimenter and Analyzer with maintenance packages.

multichannelsystems.com
4Accessories and Consumables
TypeHardware Sales
Description

Peripheral equipment including perfusion systems, micromanipulators, cables, chambers, replacement parts, and specialized accessories for specific applications.

multichannelsystems.com
5Service Plans
TypeProfessional Services
Description

MEA Systems Service Plans including software updates and support, typically offered as 2-year maintenance packages.

multichannelsystems.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Pricing details4 tiers
1MEA Systems - Complete recording systems
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Complete systems including MEA2100, MEA2100-Mini, Multiwell-MEA, CMOS-MEA5000, W2100 wireless, ME2100, and Beta-Screen systems. Pricing requires quote request or account login.

multichannelsystems.com
2Microelectrode Arrays - Consumable electrodes
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Disposable electrode arrays available in various configurations. Standard MEAs, CMOS-MEAs, FlexMEAs, and specialty arrays. Volume pricing potentially available through account management.

multichannelsystems.com
3Software - Data acquisition and analysis
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Software packages including Multi Channel Suite, Beta-Screen, and specialized analysis tools. Typically bundled with 2-year maintenance and support packages.

multichannelsystems.com
4Accessories and peripherals
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Perfusion systems (PPS2, CVP), replacement parts, chambers, and specialized accessories. Available through online shop for registered accounts.

multichannelsystems.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Multi Channel Systems designs, manufactures, and sells microelectrode array (MEA) systems and related electrophysiology instrumentation for in vitro and in vivo research, spanning complete recording platforms (MEA2100 family, CMOS-MEA5000, Multiwell-MEA, W2100 wireless, Beta-Screen), disposable microelectrode arrays, proprietary acquisition/analysis software, stimulus generators, perfusion equipment, and accessory hardware. Customers are primarily research institutions, pharmaceutical drug discovery labs, and universities conducting neuroscience, cardiac safety, and diabetes research.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Recording capacity from 4 to 4225 channels depending on system configuration
+3 more records
Product overview1 text field

Multi Channel Systems (MCS) is a manufacturer of electrophysiology equipment specializing in microelectrode array (MEA) systems. The product portfolio centers on MEA2100-Systems (60-256 channels) and MEA2100-Mini-Systems for in vitro research, supplemented by high-throughput Multiwell-MEA-Systems (24/96-well, up to 1152 electrodes) and high-resolution CMOS-MEA5000-Systems (4225 electrodes, sub-cellular resolution). For specialized applications, MCS offers MEA2100-Beta-Screen-Systems for diabetes research and Incub8 for combined optical/electrophysiological recording in incubators. The portfolio also includes wireless (W2100) and tethered (ME2100) in vivo systems, stimulus generators (STG5, STG3000), perfusion equipment, and distributed brands from HEKA and Warner Instruments. Recent innovations include Mesh MEA for organoid research, IntraCell (laser-based optoporation for intracellular recordings), and AcadeMEA (entry-level system). All systems operate with proprietary Multi Channel Suite, Multiwell-Screen, CMOS-MEA-Control, and Beta-Screen software platforms.

Product and service28 records
1MEA2100-System Family
CategoryCore Product
Description

Universal in vitro microelectrode array system for cardiac, neuronal, and stem cell applications with 60, 120, or 256 electrode configurations, integrated stimulation, temperature control, perfusion, and Multi Channel Suite software.

2MEA2100-Mini-System
CategoryCore Product
Description

Compact MEA system with a small footprint designed to operate inside humidified CO2 incubators; records from 60-electrode MEAs with integrated heating and stimulation capabilities.

3Multiwell-MEA-System
CategoryCore Product
Description

High-throughput in vitro system supporting standard 24- and 96-well plate formats with up to 1,152 electrodes and a 50 kHz sampling rate for drug screening and safety pharmacology applications.

4CMOS-MEA5000-System
CategoryCore Product
Description

High-resolution in vitro electrophysiology system based on CMOS technology offering 4,225 recording electrodes and 1,024 stimulation sites with 25 kHz sampling for sub-cellular recordings; available with 16 or 32 µm sensor pitch.

5MEA2100-Beta-Screen-System
CategorySpecialized Product
Description

In vitro recording system optimized for diabetes research with beta cells in intact islets of Langerhans, supporting up to 40 islets simultaneously with non-invasive medium-throughput screening capabilities.

6W2100-System (Wireless)
CategoryCore Product
Description

All-in-one wireless in vivo recording and stimulation system with lightweight headstages (4-32 channels), electrical and optical stimulation options, and synchronized video-to-data recording for freely roaming animals.

7ME2100-System
CategoryCore Product
Description

Tethered in vivo/ex vivo electrophysiology system with 32-256 recording channels, 24-bit A/D resolution, 50 kHz sampling rate, and electrical and optical stimulation options for brain research and Langendorff heart applications.

8Mesh MEA
CategoryCore Product
Description

Microelectrode array chip with 60 electrodes on a 7µm-thin polyimide mesh that enables cells to grow around electrodes for true-to-life recordings from inside organoids without compromising structure.

9Incub8 Multiwell MEA System
CategoryCore Product
Description

MEA system combining optical data with electrophysiological data in a single recording, operating from inside a humidified CO2 incubator for translatable and reproducible data.

10AcadeMEA Single-well MEA System
CategoryCore Product
Description

Entry-level MEA system designed for labs focused on learning, discovery, and early-stage research, combining simplified hardware with MEA2100 platform performance of 60 or 120 channels.

11IntraCell
CategoryCore Product
Description

Laser-based optoporation system by Foresee Biosystems that, when used with MCS MEA systems, allows capture of high-quality intracellular action potentials from both 2D cardiac monolayers and 3D cardiac organoids.

12IFB-C Interface Board
CategoryAccessory/Component
Description

Universal interface board with freely programmable DSP for real-time signal detection and feedback, up to 50 kHz sampling rate, and SuperSpeed USB 3.0 communication with up to three different headstage types.

13Microelectrode Arrays (MEAs)
CategoryConsumable/Component
Description

Disposable microelectrode arrays with 32, 60, 120, or 252 electrodes in various layouts including standard, multiwell plates (24 or 96 wells), CMOS arrays, and flexible FlexMEAs for different research applications.

14FlexMEA
CategoryConsumable/Component
Description

Flexible polyimide foil microelectrode arrays (EcoFlex and Standard versions) available with 24-72 electrodes; standard FlexMEAs (12µm thick) have titanium nitride electrodes and EcoFlexMEAs (50µm thick) have gold electrodes.

15CMOS-MEAs
CategoryConsumable/Component
Description

CMOS-based microelectrode arrays with 4,225 recording electrodes and 1,024 stimulation sites, available with 16µm or 32µm electrode spacing in a 65x65 grid, with or without culture/slice chambers.

16STG5 Stimulus Generator
CategoryAccessory
Description

Stimulus generator for electrical and optical stimulation in electrophysiology experiments.

17STG3000 Series
CategoryAccessory
Description

Programmable stimulus generator series used with MEA systems.

18Multi Channel Suite Software
CategorySoftware
Description

Free data acquisition software used with MEA2100 and W2100 systems.

19Beta-Screen Experimenter
CategorySoftware
Description

Software optimized for long-term experiments with beta cells in diabetes research (version 2.12.0).

20Beta-Screen Analyzer
CategorySoftware
Description

Software optimized for analyzing long-term experiments with beta cells in diabetes research (version 2.15.3).

21PPS2 Peristaltic Perfusion System
CategoryAccessory
Description

Peristaltic perfusion system with two independent pumps for controlling fluid flow in electrophysiology experiments.

22CVP Constant Vacuum Pump
CategoryAccessory
Description

Precision vacuum pump with a differential pressure sensor for pressure control in MEA systems.

23MEA Xpress
CategoryCore Product
Description

Automated liquid handling robot with integrated Multiwell-MEA-System for streamlined workflow automation.

24Roboocyte2
CategoryCore Product
Description

Fully automated injection and TEVC system for Xenopus oocyte research with drug screening in 96 wells.

25HiClamp
CategoryCore Product
Description

Automated system for Xenopus oocyte research using extremely small compound volumes.

26Roboinject
CategoryCore Product
Description

Automated injection system for Xenopus oocyte research.

27Transparent 24-well Plate with Gold Electrodes on PET
CategoryConsumable/Component
Description

New transparent 24-well plate format for MEA systems with gold electrodes on PET.

28MEA Systems Service Plans
CategoryService
Description

Service plans for MEA systems including software updates and support, typically offered as 2-year maintenance packages.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership to combine Foresee Biosystems' IntraCell laser-based optoporation technology with MCS MEA systems. Enables researchers to capture high-quality intracellular action potentials from both 2D cardiac monolayers and 3D cardiac organoids. Sets new standards for intracellular electrophysiology research.

Strategic tierCoreTypeTechnology or Integration
Description

Long-standing collaboration with NMI in Reutlingen, Germany for production of FlexMEA products. NMI produces high-quality MEAs using biocompatible materials with established quality controls and production processes refined over many years of collaboration.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Multi Channel Systems is a brand within Harvard Bioscience family of companies. Harvard Bioscience combines expertise from over a dozen brands advancing pre-clinical research in cellular and molecular markets. MCS is part of Smart Ephys division alongside HEKA Elektronik and Warner Instruments.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Neuralink is developing high-channel-count implantable neural recording interfaces for in vivo applications, representing an emerging alternative to MCS's W2100 wireless and ME2100 in vivo electrophysiology systems.

TypeBroad incumbent
Description

Bruker's cellular analysis business (formerly including Cellular Analysis / Fluxion) and broader life-science instruments compete in adjacent electrophysiology and cell-analysis markets served by MCS.

TypeDirect peer
Description

Blackrock manufactures in vivo electrophysiology recording systems (CerePlex, NeuroPort) used in neuroscience and BCI research, competing with MCS's W2100 wireless and ME2100 in vivo MEA systems.

TypeBroad incumbent
Description

Thermo Fisher's analytical instruments and laboratory products divisions include cell-analysis and screening platforms used in similar pharma and academic research workflows as MCS's MEA systems.

TypeBroad incumbent
Description

Molecular Devices offers a broad portfolio including patch clamp amplifiers (Axopatch, MultiClamp) and imaging systems that overlap with MCS's electrophysiology offerings as part of Danaher's larger life-science instrument portfolio.

TypeDirect peer
Description

Nanion offers automated patch clamp (Port-a-Patch, SyncroPatch) and MEA systems for ion-channel research and cardiotoxicity screening, overlapping with MCS's electrophysiology and drug-safety portfolio.

TypeDirect peer
Description

Sophion develops automated patch clamp platforms (QPatch) for ion channel drug discovery, directly competing with MCS's HEKA patch clamp offerings within the Smart Ephys division.

TypeDirect peer
Description

Axion's Maestro platform is the leading high-throughput MEA system for cardiotoxicity screening and neural assays, directly competing with MCS's Multiwell-MEA-System in pharma drug-safety workflows.

TypeDirect peer
Description

3Brain produces CMOS-based high-resolution MEA platforms for in vitro electrophysiology, competing head-to-head with MCS's CMOS-MEA5000 in sub-cellular and network neuroscience applications.

TypeDirect peer
Description

Swiss-based MaxWell Biosystems develops high-density CMOS MEA platforms (MaxOne, MaxTwo) for single-cell and network electrophysiology, directly overlapping with MCS's CMOS-MEA5000 in neuroscience research.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses1 record

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Multi Channel Systems

Electrophysiology Equipmentmultichannelsystems.com

Multi Channel Systems MCS GmbH manufactures microelectrode array (MEA) electrophysiology systems, consumable electrode arrays, and software for neuroscience, pharmaceutical drug discovery, cardiotoxicity, and diabetes research. It is a wholly-owned subsidiary of Harvard Bioscience Inc. (NASDAQ: HBIO), headquartered in Reutlingen, Germany.

What Multi Channel Systems does

Multi Channel Systems MCS GmbH (MCS) is a German manufacturer of microelectrode array (MEA) electrophysiology systems, founded in 1996 and headquartered in Reutlingen, Baden-Württemberg. The company operates as a wholly-owned subsidiary of Harvard Bioscience, Inc. (NASDAQ: HBIO) and is grouped, with HEKA Elektronik and Warner Instruments, into Harvard Bioscience's Smart Ephys division serving pre-clinical research markets. MCS sells to academic neuroscience researchers, pharmaceutical and biotech drug discovery and safety pharmacology groups, and diabetes research institutions globally, with direct sales and e-commerce coverage in Europe, Australia, and New Zealand and third-party distributors elsewhere.

MCS's portfolio spans in vitro and in vivo electrophysiology. The core platform is the MEA2100 system family (60–256 electrodes, 24-bit A/D, integrated stimulation, temperature control, perfusion, DC–10 kHz bandwidth). Above it sits the CMOS-MEA5000 (4,225 recording electrodes and 1,024 stimulation sites on a 65×65 grid at 16–32 µm pitch, 25 kHz sampling) for sub-cellular resolution, and the Multiwell-MEA (24/96-well format, up to 1,152 electrodes, 50 kHz) for high-throughput screening. Specialized offerings include the Beta-Screen system for intact islet recordings in diabetes research, the Incub8 Multiwell MEA for combined optical and electrophysiological recording inside a CO2 incubator, the wireless W2100 and tethered ME2100 for in vivo work, and — since 2024 — the AcadeMEA entry-level system and MEA Xpress automated liquid-handling platform. The 2025 Mesh MEA (a 7 µm polyimide 60-electrode mesh enabling inside-organoid recordings) and the 2024 Foresee Biosystems IntraCell partnership (laser-based optoporation for intracellular action potentials) extend the portfolio into 3D and intracellular assays. Software (Multi Channel Suite, Multiwell-Screen, CMOS-MEA-Control, Beta-Screen Experimenter and Analyzer) and a universal interface board (IFB-C, programmable DSP, USB 3.0) complete the workflow. Disposable MEAs in standard, CMOS, FlexMEA, and EcoFlexMEA variants, plus stimulus generators, perfusion, and micromanipulator accessories, supply the consumables and peripherals.

Revenue is generated through hardware system sales, recurring software licenses and 2-year service/maintenance plans, and disposable MEA consumables. Pricing is quote-based and gated to registered B2B accounts. The go-to-market combines a direct European/Australian field-sales motion (with 'Request a Demo' and 'Schedule a Meeting' CTAs), a B2B online shop, conference and webinar participation, and a worldwide distributor network outside direct territories. With 51–100 employees and a single R&D-and-manufacturing footprint, MCS runs a specialized, high-touch scientific-tools model where the installed base of instruments and consumable arrays drives recurring revenue.

Multi Channel Systems firmographics

Firmographics
Name
Multi Channel Systems
Legal name
Multi Channel Systems MCS GmbH
Website
https://multichannelsystems.com
Company type
Private
Founded year
1996
Operating status
Operating
Headcount range
11–50 employees
Short description
Multi Channel Systems MCS GmbH manufactures microelectrode array (MEA) electrophysiology systems, consumable electrode arrays, and software for neuroscience, pharmaceutical drug discovery, cardiotoxicity, and diabetes research. It is a wholly-owned subsidiary of Harvard Bioscience Inc. (NASDAQ: HBIO), headquartered in Reutlingen, Germany.
Ownership category
akta.pro rank

Multi Channel Systems industry classification

Industry
Product category
Electrophysiology Equipment
NAICS
Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Analytical Laboratory Instrument Manufacturing (334516), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Laboratory Analytical Instruments (3826), Instruments For Meas & Testing Of Electricity & Elec Signals (3825)
akta.pro industry
PRIMARYHDAHALAK
Biosensors & Lab-on-Chip (BioMEMS)
SECONDARYHDAHALAO
Sensor Fusion, Interface ICs & Modules (AFE/Readout/Packaging/Calibration)
SECONDARYHDAHAAAG
Sensors, MEMS & Imaging ICs

Keywords

  • Microelectrode array systems
  • Electrophysiology equipment
  • Neuroscience research instruments
  • Cardiotoxicity screening tools
  • In vivo recording systems

Where Multi Channel Systems is headquartered

Location

Headquarters

HQ city
Reutlingen
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

Multi Channel Systems business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. MEA Systems Hardware: Complete microelectrode array systems including amplifiers, headstages, interface boards, and data acquisition units for in vitro and in vivo electrophysiology research.
  2. Microelectrode Arrays: Disposable MEA chips including standard, CMOS, FlexMEA, and specialized arrays. Electrodes include titanium nitride, gold, and PEDOT coatings with various layouts (24-4225 electrodes).
  3. Software Licenses and Updates: Data acquisition and analysis software including Multi Channel Suite, Multiwell-Screen, CMOS-MEA-Control, Beta-Screen Experimenter and Analyzer with maintenance packages.
  4. Accessories and Consumables: Peripheral equipment including perfusion systems, micromanipulators, cables, chambers, replacement parts, and specialized accessories for specific applications.
  5. Service Plans: MEA Systems Service Plans including software updates and support, typically offered as 2-year maintenance packages.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goMEA Systems - Complete recording systems
Unit PricingPay-as-you-goMicroelectrode Arrays - Consumable electrodes
SubscriptionMulti-year contractSoftware - Data acquisition and analysis
Unit PricingPay-as-you-goAccessories and peripherals

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Multi Channel Systems product offering

Product offering

Core offering

Multi Channel Systems designs, manufactures, and sells microelectrode array (MEA) systems and related electrophysiology instrumentation for in vitro and in vivo research, spanning complete recording platforms (MEA2100 family, CMOS-MEA5000, Multiwell-MEA, W2100 wireless, Beta-Screen), disposable microelectrode arrays, proprietary acquisition/analysis software, stimulus generators, perfusion equipment, and accessory hardware. Customers are primarily research institutions, pharmaceutical drug discovery labs, and universities conducting neuroscience, cardiac safety, and diabetes research.

Product overview

Multi Channel Systems (MCS) is a manufacturer of electrophysiology equipment specializing in microelectrode array (MEA) systems. The product portfolio centers on MEA2100-Systems (60-256 channels) and MEA2100-Mini-Systems for in vitro research, supplemented by high-throughput Multiwell-MEA-Systems (24/96-well, up to 1152 electrodes) and high-resolution CMOS-MEA5000-Systems (4225 electrodes, sub-cellular resolution). For specialized applications, MCS offers MEA2100-Beta-Screen-Systems for diabetes research and Incub8 for combined optical/electrophysiological recording in incubators. The portfolio also includes wireless (W2100) and tethered (ME2100) in vivo systems, stimulus generators (STG5, STG3000), perfusion equipment, and distributed brands from HEKA and Warner Instruments. Recent innovations include Mesh MEA for organoid research, IntraCell (laser-based optoporation for intracellular recordings), and AcadeMEA (entry-level system). All systems operate with proprietary Multi Channel Suite, Multiwell-Screen, CMOS-MEA-Control, and Beta-Screen software platforms.

Differentiator

Problem solved

Functional benefit

Products and services

  • MEA2100-System Family Universal in vitro microelectrode array system for cardiac, neuronal, and stem cell applications with 60, 120, or 256 electrode configurations, integrated stimulation, temperature control, perfusion, and Multi Channel Suite software.
  • MEA2100-Mini-System Compact MEA system with a small footprint designed to operate inside humidified CO2 incubators; records from 60-electrode MEAs with integrated heating and stimulation capabilities.
  • Multiwell-MEA-System High-throughput in vitro system supporting standard 24- and 96-well plate formats with up to 1,152 electrodes and a 50 kHz sampling rate for drug screening and safety pharmacology applications.
  • CMOS-MEA5000-System High-resolution in vitro electrophysiology system based on CMOS technology offering 4,225 recording electrodes and 1,024 stimulation sites with 25 kHz sampling for sub-cellular recordings; available with 16 or 32 µm sensor pitch.
  • MEA2100-Beta-Screen-System In vitro recording system optimized for diabetes research with beta cells in intact islets of Langerhans, supporting up to 40 islets simultaneously with non-invasive medium-throughput screening capabilities.
  • W2100-System (Wireless) All-in-one wireless in vivo recording and stimulation system with lightweight headstages (4-32 channels), electrical and optical stimulation options, and synchronized video-to-data recording for freely roaming animals.
  • ME2100-System Tethered in vivo/ex vivo electrophysiology system with 32-256 recording channels, 24-bit A/D resolution, 50 kHz sampling rate, and electrical and optical stimulation options for brain research and Langendorff heart applications.
  • Mesh MEA Microelectrode array chip with 60 electrodes on a 7µm-thin polyimide mesh that enables cells to grow around electrodes for true-to-life recordings from inside organoids without compromising structure.
  • Incub8 Multiwell MEA System MEA system combining optical data with electrophysiological data in a single recording, operating from inside a humidified CO2 incubator for translatable and reproducible data.
  • AcadeMEA Single-well MEA System Entry-level MEA system designed for labs focused on learning, discovery, and early-stage research, combining simplified hardware with MEA2100 platform performance of 60 or 120 channels.
  • IntraCell Laser-based optoporation system by Foresee Biosystems that, when used with MCS MEA systems, allows capture of high-quality intracellular action potentials from both 2D cardiac monolayers and 3D cardiac organoids.
  • IFB-C Interface Board Universal interface board with freely programmable DSP for real-time signal detection and feedback, up to 50 kHz sampling rate, and SuperSpeed USB 3.0 communication with up to three different headstage types.
  • Microelectrode Arrays (MEAs) Disposable microelectrode arrays with 32, 60, 120, or 252 electrodes in various layouts including standard, multiwell plates (24 or 96 wells), CMOS arrays, and flexible FlexMEAs for different research applications.
  • FlexMEA Flexible polyimide foil microelectrode arrays (EcoFlex and Standard versions) available with 24-72 electrodes; standard FlexMEAs (12µm thick) have titanium nitride electrodes and EcoFlexMEAs (50µm thick) have gold electrodes.
  • CMOS-MEAs CMOS-based microelectrode arrays with 4,225 recording electrodes and 1,024 stimulation sites, available with 16µm or 32µm electrode spacing in a 65x65 grid, with or without culture/slice chambers.
  • STG5 Stimulus Generator Stimulus generator for electrical and optical stimulation in electrophysiology experiments.
  • STG3000 Series Programmable stimulus generator series used with MEA systems.
  • Multi Channel Suite Software Free data acquisition software used with MEA2100 and W2100 systems.
  • Beta-Screen Experimenter Software optimized for long-term experiments with beta cells in diabetes research (version 2.12.0).
  • Beta-Screen Analyzer Software optimized for analyzing long-term experiments with beta cells in diabetes research (version 2.15.3).
  • PPS2 Peristaltic Perfusion System Peristaltic perfusion system with two independent pumps for controlling fluid flow in electrophysiology experiments.
  • CVP Constant Vacuum Pump Precision vacuum pump with a differential pressure sensor for pressure control in MEA systems.
  • MEA Xpress Automated liquid handling robot with integrated Multiwell-MEA-System for streamlined workflow automation.
  • Roboocyte2 Fully automated injection and TEVC system for Xenopus oocyte research with drug screening in 96 wells.
  • HiClamp Automated system for Xenopus oocyte research using extremely small compound volumes.
  • Roboinject Automated injection system for Xenopus oocyte research.
  • Transparent 24-well Plate with Gold Electrodes on PET New transparent 24-well plate format for MEA systems with gold electrodes on PET.
  • MEA Systems Service Plans Service plans for MEA systems including software updates and support, typically offered as 2-year maintenance packages.

Quantifiable outcome

  • Recording capacity from 4 to 4225 channels depending on system configuration
  • +3 more outcomes

Companies that use Multi Channel Systems

Customer profile

Segments4 records

Ideal customer profiles4 records

Multi Channel Systems technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Multi Channel Systems partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Foresee BiosystemscoreStrategic or Co-development PartnerPartnership to combine Foresee Biosystems' IntraCell laser-based optoporation technology with MCS MEA systems. Enables researchers to capture high-quality intracellular action potentials from both 2D cardiac monolayers and 3D cardiac organoids. Sets new standards for intracellular electrophysiology research.
  • NMI (Natural and Medical Sciences Institute)coreTechnology or IntegrationLong-standing collaboration with NMI in Reutlingen, Germany for production of FlexMEA products. NMI produces high-quality MEAs using biocompatible materials with established quality controls and production processes refined over many years of collaboration.
  • Harvard BiosciencecoreStrategic or Co-development PartnerMulti Channel Systems is a brand within Harvard Bioscience family of companies. Harvard Bioscience combines expertise from over a dozen brands advancing pre-clinical research in cellular and molecular markets. MCS is part of Smart Ephys division alongside HEKA Elektronik and Warner Instruments.

Scale indicators3 records

Recent moves5 records

Expansion highlights6 records

Multi Channel Systems competitors and assessment

Company assessment

Emerging players

  • Neuralink: Neuralink is developing high-channel-count implantable neural recording interfaces for in vivo applications, representing an emerging alternative to MCS's W2100 wireless and ME2100 in vivo electrophysiology systems.

Broad incumbents

  • Bruker: Bruker's cellular analysis business (formerly including Cellular Analysis / Fluxion) and broader life-science instruments compete in adjacent electrophysiology and cell-analysis markets served by MCS.
  • Thermo Fisher Scientific: Thermo Fisher's analytical instruments and laboratory products divisions include cell-analysis and screening platforms used in similar pharma and academic research workflows as MCS's MEA systems.
  • Molecular Devices (Danaher): Molecular Devices offers a broad portfolio including patch clamp amplifiers (Axopatch, MultiClamp) and imaging systems that overlap with MCS's electrophysiology offerings as part of Danaher's larger life-science instrument portfolio.

Direct peers

  • Blackrock Microsystems: Blackrock manufactures in vivo electrophysiology recording systems (CerePlex, NeuroPort) used in neuroscience and BCI research, competing with MCS's W2100 wireless and ME2100 in vivo MEA systems.
  • Nanion Technologies: Nanion offers automated patch clamp (Port-a-Patch, SyncroPatch) and MEA systems for ion-channel research and cardiotoxicity screening, overlapping with MCS's electrophysiology and drug-safety portfolio.
  • Sophion Bioscience: Sophion develops automated patch clamp platforms (QPatch) for ion channel drug discovery, directly competing with MCS's HEKA patch clamp offerings within the Smart Ephys division.
  • Axion Biosystems: Axion's Maestro platform is the leading high-throughput MEA system for cardiotoxicity screening and neural assays, directly competing with MCS's Multiwell-MEA-System in pharma drug-safety workflows.
  • 3Brain: 3Brain produces CMOS-based high-resolution MEA platforms for in vitro electrophysiology, competing head-to-head with MCS's CMOS-MEA5000 in sub-cellular and network neuroscience applications.
  • MaxWell Biosystems: Swiss-based MaxWell Biosystems develops high-density CMOS MEA platforms (MaxOne, MaxTwo) for single-cell and network electrophysiology, directly overlapping with MCS's CMOS-MEA5000 in neuroscience research.

Market position

Strengths5 records

Weaknesses1 record

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Multi Channel Systems social profiles

Digital presence

Multi Channel Systems financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Multi Channel Systems leadership team

Management profile

Number of profiles

Profiles2 records

Multi Channel Systems funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Multi Channel Systems M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Multi Channel Systems

What does Multi Channel Systems do?

Multi Channel Systems designs, manufactures, and sells microelectrode array (MEA) systems and related electrophysiology instrumentation for in vitro and in vivo research, spanning complete recording platforms (MEA2100 family, CMOS-MEA5000, Multiwell-MEA, W2100 wireless, Beta-Screen), disposable microelectrode arrays, proprietary acquisition/analysis software, stimulus generators, perfusion equipment, and accessory hardware. Customers are primarily research institutions, pharmaceutical drug discovery labs, and universities conducting neuroscience, cardiac safety, and diabetes research.

Is Multi Channel Systems a public or private company?

Multi Channel Systems is a private company. It is classified as corporate owned and is currently operating.

When was Multi Channel Systems founded?

Multi Channel Systems was founded in 1996. It employs 11 to 50 people.

Where is Multi Channel Systems based?

Multi Channel Systems is headquartered in Reutlingen, Germany, in the Europe region.

How does Multi Channel Systems make money?

Five revenue lines are on record. MEA Systems Hardware is the primary driver. The others are microelectrode Arrays, software Licenses and Updates, accessories and Consumables and service Plans.

Who are Multi Channel Systems's main competitors?

Neuralink is listed as an emerging player. Broad incumbents are Bruker, Thermo Fisher Scientific and Molecular Devices (Danaher). Direct peers are Blackrock Microsystems, Nanion Technologies, Sophion Bioscience, Axion Biosystems, 3Brain and MaxWell Biosystems.

Does Multi Channel Systems have an API?

No public API is recorded for Multi Channel Systems.

What industry is Multi Channel Systems in?

Multi Channel Systems's product category is Electrophysiology Equipment. Its primary akta.pro industry code is HDAHALAK, Biosensors & Lab-on-Chip (BioMEMS), with a secondary code of HDAHALAO, Sensor Fusion, Interface ICs & Modules (AFE/Readout/Packaging/Calibration). Its NAICS code is 33451 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
European UnionNetworked Distributed Neural Interfaces for Interference-Based Brain StimulationThe provided text is a structured data extract from an EU Horizon collaboration network page listing partner organizations for the project titled 'Networked Distributed Neural Interfaces for Interference-Based Brain Stimulation'. It details participating entities including NEUROCONN GMBH, G.TEC MEDICAL ENGINEERING GMBH, MULTI CHANNEL SYSTEMS MCS GMBH, and MED-EL ELEKTROMEDIZINISCHE GERATE GMBH, along with academic and research institutions. The content consists entirely of administrative metadata such as addresses, SME status declarations, and financial contribution fields rather than narrative news reporting.PR NewswireClose Relationships with Companion Animals favoring adoption of Minimally Invasive Procedures to alleviate Post-Surgical Pain charts Growth in Veterinary Endoscopes Market, Market Projected to expandA Transparency Market Research report analyzes the projected growth of the global veterinary endoscopes market, driven by rising pet ownership, increasing demand for minimally invasive procedures, and government support for veterinary healthcare in emerging economies like India. The report highlights that product advancements in video imaging technology and the pain-factor advantages of endoscopy over traditional veterinary medicine are accelerating adoption among pet owners. Key market players include Harvard Bioscience, which has pursued strategic acquisitions (Multi Channel System GmbH and Triangle BioSystems Inc.) to expand its portfolio in the veterinary endoscopy segment.GlobeNewswireHarvard Bioscience Subsidiary Multi Channel Systems Launches Beta Cell Screening System for Diabetes Research, Entering New Segment of Electrophysiology MarketMulti Channel Systems, a Harvard Bioscience subsidiary, launched the Beta Cell-System, a non-invasive beta cell screening system for diabetes research. It uses multi electrode array technology to measure intact islets, offering higher throughput and easier handling than patch-clamp methods. The system enters a new electrophysiology market segment.GlobeNewswireHarvard Bioscience Acquires Multi Channel Systems MCS GmbH and Triangle BioSystems, Inc.Harvard Bioscience acquired Multi Channel Systems MCS GmbH and Triangle BioSystems, Inc. for about $11 million in cash. The acquisitions are expected to add $7.5 million to $8.5 million in revenue in 2015 and be accretive to earnings. The deals expand Harvard Bioscience's electrophysiology product line.